Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

Bibliographic Details
Main Authors:	Rosanna Squitti, Carlo Salustri, Mauro Rongioletti, Mariacristina Siotto
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-09-01
Series:	Frontiers in Neurology
Subjects:	copper Alzheimer’s disease beta-amyloid peptide chelation therapy metals
Online Access:	http://journal.frontiersin.org/article/10.3389/fneur.2017.00503/full

Similar Items

Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
by: Soghra Bagheri, et al.
Published: (2018-01-01)

Probable Reasons for Neuron Copper Deficiency in the Brain of Patients with Alzheimer’s Disease: The Complex Role of Amyloid
by: Soghra Bagheri, et al.
Published: (2022-01-01)

Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease
by: Ignazio Schino, et al.
Published: (2022-12-01)

Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
by: Amit Pal, et al.
Published: (2021-10-01)

Developments in the Role of Iron Imbalance in the Pathogenesis of Alzheimer's Disease
by: GUO Shuang, CHEN Fengyan, YIN Xiang, WANG Lu, GUO Xuefeng, YU Qiming, ZOU Zhenyou, SHU Wei
Published: (2022-01-01)

Distribution in Rat Blood and Brain of TDMQ20, a Copper Chelator Designed as a Drug-Candidate for Alzheimer’s Disease
by: Lan Huang, et al.
Published: (2022-12-01)

Regulatory miRNAs in Cardiovascular and Alzheimer’s Disease: A Focus on Copper
by: Anna Sacco, et al.
Published: (2022-03-01)

New Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders
by: Rita Tosto, et al.
Published: (2023-09-01)

Copper and cuproptosis: new therapeutic approaches for Alzheimer’s disease
by: Xiao Li, et al.
Published: (2023-12-01)

Role of Alginate Composition on Copper Ion Uptake in the Presence of Histidine or Beta-Amyloid
by: Cynthia Regina Albrecht Mahl, et al.
Published: (2022-11-01)

Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation
by: Marianna Tosato, et al.
Published: (2022-06-01)

Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients
by: Rosanna Squitti, et al.
Published: (2006-01-01)

EFFECT OF CHELATED AND MINERAL FORMS OF MICRONUTRIENTS ON THEIR CONTENT IN LEAVES AND THE YIELD OF LETTUCE. PART II. COPPER
by: Elzbieta Kozik, et al.
Published: (2008-09-01)

Influence of chelating agents on structural, optical, and electromgnetic interference properties of copper selenide nanoparticles synthesized via microwave-assisted method
by: Garba, Shitu Ibrahim
Published: (2021)

Benefits and drawbacks of current copper chelators in Wilson disease
by: Ioan-Cristian Lupescu, et al.
Published: (2023-03-01)

Progress on the correlation between exosomal microRNAs and Alzheimer's disease
by: DIAO Hua-qiong, LI Xiao-li, LIN Liang-yin, LIU Hai-peng, CHEN Hong-jing, DING Hai-yue, WEI Dan
Published: (2020-11-01)

Alzheimer’s disease as an inflammatory disease
by: Bolós Marta, et al.
Published: (2017-02-01)

Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer’s Patients
by: Mohamed Abbas
Published: (2021-03-01)

Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites
by: Felix S. Meier‐Stephenson, et al.
Published: (2022-01-01)

Synthesis and Spectral Studies on Heteroleptic Chelated Copper (II) Complexes of Diamine and Acetylacetonate
by: Hamid Golchoubian, et al.
Published: (2012-01-01)

Zinc and copper in transfusion-dependent thalassemia patients on different iron chelators in Basrah: A case-control study
by: Balqees Kadhim Hasan, et al.
Published: (2023-01-01)

Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
by: Nahid Ahmadian, et al.
Published: (2018-09-01)

Ginkgo biloba extract-loaded PLGA microcapsules generated from microfluidics for Alzheimer's disease treatment
by: Xiao Zhang, et al.
Published: (2024-02-01)

Fluorinated Molecules and Nanotechnology: Future ‘Avengers’ against the Alzheimer’s Disease?
by: Meghna Dabur, et al.
Published: (2020-04-01)

Therapeutic Effect of Erythropoietin on Alzheimer’s Disease by Activating the Serotonin Pathway
by: Kyu-Ho Shim, et al.
Published: (2022-07-01)

Copper Chelation via beta-alanine extends lifespan in a C. elegans model of Alzheimer's Disease
by: Arnulfo Pulido, et al.
Published: (2023-06-01)

Abeta Peptide and Alzheimer's Disease [electronic resources]: Celebrating a Century of Research/
by: Barrow, Colin J., et al.
Published: (2007)

Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer’s Disease
by: Sergey A. Kozin, et al.
Published: (2023-12-01)

Comparison of potential plasma biomarkers in Alzheimer’s disease and neurodegenerative dementias in Pakistani population
by: Tehniat Faraz Ahmed, et al.
Published: (2023-09-01)

Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
by: Hee-Do Kim, et al.
Published: (2023-05-01)

Extraction of Melanin in Apricot Kernel Shell and the Optimization of Chelating Process of Its Metal Chelates
by: Li GAO, et al.
Published: (2022-07-01)

Chelators for Treatment of Iron and Copper Overload: Shift from Low-Molecular-Weight Compounds to Polymers
by: Martin Hruby, et al.
Published: (2021-11-01)

Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy
by: Rosanna Squitti, et al.
Published: (2020-08-01)

Alzheimer's disease related heart structural and functional damage
by: Shu⁃yu LIU, et al.
Published: (2023-04-01)

Aggregation Limiting Cell-Penetrating Peptides Derived from Protein Signal Sequences
by: Ly Porosk, et al.
Published: (2023-02-01)

Selective recovery of copper from copper tailings and wastewater using chelating resins with bis-picolylamine functional groups
by: Kosisochi Ibebunjo, et al.
Published: (2024-03-01)

Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer’s-Related Aβ Peptide
by: Paulina Gonzalez, et al.
Published: (2022-09-01)

HSV-1 and Alzheimer’s Disease: more than a hypothesis
by: Roberto ePiacentini, et al.
Published: (2014-05-01)

Non-Ceruloplasmin Copper Identifies a Subtype of Alzheimer’s Disease (CuAD): Characterization of the Cognitive Profile and Case of a CuAD Patient Carrying an <em>RGS7</em> Stop-Loss Variant
by: Rosanna Squitti, et al.
Published: (2023-03-01)

Can copper amino acid chelates reduce the physiological strain of growing rabbits under summer conditions?
by: Fesal Goodb, et al.
Published: (2022-12-01)